FDA Advisory Committee Recommends Approval of REMICADE® for Treatment of ... - PR Newswire (press release)

FDA Advisory administrative unit Recommends Approval of REMICADE® for Treatment of ... PR Newswire (press release) In addition, REMICADE® is approved for the attention of moderately to gravely active rheumatoid arthritis, progressive psoriatic arthritis, active ankylosing spondylitis and chronic, wicked plaque psoriasis . "We are pleased with the advisory committee's ... and more » Link To Article